Pharmaceutical intermediates
Seltorexant Intermediates
4 pharmaceutical intermediates for Seltorexant. Indication: Major Depressive Disorder (MDD); Insomnia.
About Seltorexant
- Originator
- Janssen Research & Development Llc
- Indication
- Major Depressive Disorder (MDD); Insomnia
Available intermediates
4 intermediates currently listed for Seltorexant. Request specifications, documentation or a quotation for any item below.
| Product Name | CAS No. | Molecular Formula | Physical Properties |
|---|---|---|---|
| Pyrrolo[3,4-c]pyrrole,2-(4,6-dimethyl-2-pyrimidinyl)octahydro- | 1293284-71-5 | / | / |
| 2-Fluoro-6-(2H-1,2,3-triazol-2-yl)benzoic acid | 1186050-58-7 | / | / |
| 2-Fluoro-6-iodobenzoic acid | 111771-08-5 | / | / |
| 5-benzyltetrahydropyrrolo[3,4-c]pyrrole-1,3(2H,3aH)-dione | 848591-86-6 | / | / |
Building toward Seltorexant?
Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.
How can we help you?
Receive insights into the latest events and regulatory updates
Sent directly to your email
Get industry insights and Unibest news here
Contact Us →